NEWS RELEASE – PreveCeutical announces further updates to the successful engineering & cell-based efficacy screening of its smart-siRNA constructs for its dual gene therapy research program. https://t.co/5sPVu9SBRi
#CSEStocks#Pharmaceutical#Biotechnology#OTCStocks
PreveCeutical Files Two Family Patents of Sol-Gel Cannabinoid Formulation And Antiviral Use & Cyclic Peptides And Uses Thereof
https://t.co/IJY9XK52Dl
The International Diabetes Federation states 1 in 10 adults worldwide are living with diabetes. PreveCeutical may have an answer. #Preveceuticals
https://t.co/tgVLGjDgIm